PAVmed Inc.
PAVM
$0.35
$0.00-1.36%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -87.28% | 226.20% | 220.36% | 162.00% | 134.45% |
| Total Depreciation and Amortization | -91.59% | -84.16% | -76.53% | -59.14% | -36.79% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 89.34% | -2,123.16% | -1,668.17% | -1,085.49% | -894.07% |
| Change in Net Operating Assets | -36.07% | -91.42% | -105.20% | -67.82% | 7.29% |
| Cash from Operations | 92.18% | 75.80% | 54.85% | 35.52% | 20.12% |
| Capital Expenditure | 91.03% | 90.24% | 92.64% | 77.27% | 34.45% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | 100.00% | -- | -- | -- | -- |
| Other Investing Activities | 100.00% | -- | -- | -- | -165.00% |
| Cash from Investing | 99.87% | -6,466.26% | -6,158.91% | -2,235.09% | -2,644.79% |
| Total Debt Issued | -- | -- | -- | -- | -100.00% |
| Total Debt Repaid | 100.00% | 100.00% | 47.88% | -572.15% | -- |
| Issuance of Common Stock | 108.66% | 156.71% | 111.63% | -7.37% | 12.83% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -93.23% | -93.28% | -51.57% | 54.96% | 143.10% |
| Cash from Financing | -83.67% | -82.91% | -39.37% | 0.36% | 39.58% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 109.12% | -84.28% | 3.82% | 8.21% | 15.58% |